660 related articles for article (PubMed ID: 19557841)
21. Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy.
Parks MH; Dawant BM; Riddle WR; Hartmann SL; Dietrich MS; Nickel MK; Price RR; Martin PR
Alcohol Clin Exp Res; 2002 Sep; 26(9):1368-80. PubMed ID: 12351932
[TBL] [Abstract][Full Text] [Related]
22. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.
Hoshino Y; Yoshikawa K; Inoue Y; Asai S; Nakamura T; Ogino T; Umeda M; Iwamoto A
Radiat Med; 1999; 17(2):115-20. PubMed ID: 10399778
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proton MR spectroscopic imaging of the mesial temporal lobe.
Arslanoglu A; Bonekamp D; Barker PB; Horská A
J Magn Reson Imaging; 2004 Nov; 20(5):772-8. PubMed ID: 15503328
[TBL] [Abstract][Full Text] [Related]
24. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
25. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
26. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
27. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
28. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
[TBL] [Abstract][Full Text] [Related]
29. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
30. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
31. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1.
Dichgans M; Herzog J; Freilinger T; Wilke M; Auer DP
Neurology; 2005 Feb; 64(4):608-13. PubMed ID: 15728280
[TBL] [Abstract][Full Text] [Related]
32. MRI, volumetry, 1H spectroscopy, and cerebropetal blood flowmetry in childhood idiopathic anatomic megalencephaly.
Koudijs SM; van der Grond J; Hoogendoorn ML; Hulshoff Pol HE; Schnack HG; Witkamp TD; Gooskens RH; van Nieuwenhuizen O; Braun KP
J Magn Reson Imaging; 2006 Aug; 24(2):282-7. PubMed ID: 16786580
[TBL] [Abstract][Full Text] [Related]
33. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
Qiu SJ; Zhang XL; Zhang Y; Jiang M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
[TBL] [Abstract][Full Text] [Related]
34. MR spectroscopy and atrophy in Gluten, Friedreich's and SCA6 ataxias.
Hadjivassiliou M; Wallis LI; Hoggard N; Grünewald RA; Griffiths PD; Wilkinson ID
Acta Neurol Scand; 2012 Aug; 126(2):138-43. PubMed ID: 22070551
[TBL] [Abstract][Full Text] [Related]
35. Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications.
Alkan A; Kutlu R; Kocak G; Sigirci A; Emul M; Dogan S; Aslan M; Sarac K; Yakinci C
Eur J Radiol; 2004 Mar; 49(3):224-8. PubMed ID: 14962651
[TBL] [Abstract][Full Text] [Related]
36. Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS.
Malucelli E; Manners DN; Testa C; Tonon C; Lodi R; Barbiroli B; Iotti S
NMR Biomed; 2009 Dec; 22(10):1003-13. PubMed ID: 19504521
[TBL] [Abstract][Full Text] [Related]
37. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
39. In vivo 1H MR spectroscopic findings in traumatic contusion of ICR mouse brain induced by fluid percussion injury.
Choi CB; Kim HY; Han DY; Kang YW; Han YM; Jeun SS; Choe BY
Eur J Radiol; 2005 Jul; 55(1):96-101. PubMed ID: 15950105
[TBL] [Abstract][Full Text] [Related]
40. Brain metabolite concentration ratios in vivo: multisite reproducibility by single-voxel 1H MR spectroscopy.
Komoroski RA; Kotrla KJ; Lemen L; Lindquist D; Diaz P; Foundas A
Magn Reson Imaging; 2004 Jun; 22(5):721-5. PubMed ID: 15172067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
